MAP2K7 and head and neck squamous cell carcinoma: The upregulation of pro-inflammatory cytokines that confers sensitivity towards MEK inhibition could therefore explain why a majority of HNSCC cell lines are responding to MEKi despite the lack of activating mutations in the Ras/Raf/MAPK pathways.